An Overview of Mucoadhesive Thermoreversible Nasal Gel
DOI:
https://doi.org/10.22270/ajprd.v9i4.994Keywords:
Mucoadhesive, thermoreversible, in situ nasal gel, Nasal DDS.Abstract
Nasal drug is a supportive delivery technique to acquire therapeutic related levels of the medicine in the blood and an sufficient bioavailability. The Drugs have been nasally administrated for entertaining and therapeutic function since premature period. Administration through Nasal route offers a striking route of drug administration for achieving total systemic drug effects to the oral and parenteral route. Nasal drug delivery include rather the large surface area of the nasal cavity and which promotes quick absorption and relatively high blood flow. To improve nasal drug absorption many attempts have been completed in the recent years to develop the residence time of therapy formulations in the nasal cavity. To get better nasal drug absorption many attempts have been completed in the recent years to enhance the residence time of remedy formulations in the nasal cavity, out of them thermoresponsive in situ gel formulation approaches are one of the very important and effective.
Downloads
References
2. Sachin C, Sagar S and Barhate S D. Advantageous nasal drug delivery system: a review. IJPSR, 2011; 2(6):1322-1336.
3. Turker S, Onur E, Ozer Y. Nasal route and drug delivery systems. Pharmacy World and
4. Science, 2004; 26(3): 137-142.
5. Alagusundaram M, Chengaiah B, Ganaprakash K, Ramkanth S, Madhusudhanahetty C, Dhachinamoorti D. Nasal Delivery System-An Overview. International journal of research in pharmaceutical sciences, 2010; 1(4):454-465.
6. Aishwarya JJ, Sheetal BG, Ravindra BS. A Review on nasal drug delivery system. World Journal of pharmacy and pharmaceutical sciences, 2014; 3(8):231-254.
7. Mayank C, Manish K, Kamla P. A review on mucoadhesive polymer used in nasal drug delivery system. J Adv Pharm Technol Res, 2011; 2(4):215-22.
8. Dhakar RC. Non-invasive Systemic Drug Delivery via Nasal Route: A Review. The African Journal of Pharmaceutical Sciences and Pharmacy, 2011; 2:114-144.
9. Muhammad UG, Mohammed HM, Alan MS and Barbara RC. Nasal Drug Delivery Systems: an overview. American Journal of Pharmacological Sciences, 2015; 3(5):110-119.
10. Kisan RJ, Manoj NG, Ishaque MS, Vilarsrao JK. and Sambjahi SP. Nasal Drug Delivery System Factors Affecting and Applications. Current Drug Therapy, 2007; 2:27-38.
11. Therese NN, Deepa MR. An Overview on In-Situ Nasal Gel for Drug Delivery. J. Pharm. Sci. & Res. 2019; 11(7):2585-2589.
12. Agrawal A, Maheshwari RK. Formulation development and evaluation of in situ nasal gel of poorly water soluble drug using mixed solvency concept. Asian J Pharm, 2011; 5:131-40.
13. Ebru A & Gülgün Y. Formulation and Evaluation of Thermoreversible in Situ Nasal Gels Containing Mometasone Furoate for Allergic Rhinitis. AAPS Pharm SciTech volume, 2017; 18:2673–2682.
14. Amir F, Marta C, Alexander S. Thermogelling properties of purified poloxamer 407. Heliyon, 2017; 3:e00390.
15. Maryam K. In situ gelling systems for drug delivery. Jundishapur J Nat Pharm Prod 2014; 9(3): e20126.
16. Swati J, Nirupama S, and Bhanudas SK. Optimization of Thermoreversible in Situ Nasal Gel of Timolol Maleate. Hindawi Publishing Corporation Scientifica, 2016; Article ID 6401267, 11.
17. Blessing AA, In Situ-Based Gels for Nose to Brain Delivery for the Treatment of Neurological Diseases. Pharmaceutics, 2018; 10:40.
18. Wang Y, Jiang S, Wang H, Bie H. A mucoadhesive thermoreversible in situ nasal gel of geniposide for neurodegenerative diseases. PLoS ONE, 2017;12(12): e0189478.
19. Richa S, Sajal S, Satya PS. Thermoreversible in-situ nasal gel formulations and their pharmaceutical evaluation for the treatment of allergic rhinitis containing extracts of moringa olifera and embelia ribes. Int J App Pharm. 2017; 9 (6):16-20.
20. Monica R, Deepak KA & Chaitanya S. Thermoreversible mucoadhesive in situ nasal gel for treatment of Parkinson’s disease. Drug Development and Industrial Pharmacy, 2017; 43(1): 142-150.
21. Sabale A, Kulkarni A, Sabale A. Nasal in Situ Gel: Novel Approach for Nasal Drug Delivery. JDDT, 2020; 10(2-s):183-97.
22. Kempwade A & Taranalli A. Formulation and evaluation of thermoreversible, mucoadhesive in situ intranasal gel of rizatriptan benzoate. J Sol-Gel Sci Technol, 2014; 72: 43–48.
23. Sheri PS & Prasanth VV. Development and evaluation of in situ nasal gel formulations of Loratadine. Research in Pharmaceutical Sciences, 2015; 10(6):466-476.
24. Amit J, Abhishek S, Sudarshan J, Gaurav S, Chhabra G, Mahesh S. Formulation and Evaluation of Thermoreversible in-situ Nasal Gel of Rizatriptan Benzoate and Caffeine. Int. J. Pharm. Sci. Rev. Res., 2018; 49(1):126-130.
25. Kailas KM, Shashikant CD, Remeth JD, Vijay DH, Vishwajeet SG, Nitin HS. Nasal Mucoadhesive in Situ Gel of Granisetron Hydrochloride using Natural Polymers. J App Pharm Sci, 2015; 5(07):084-093.
26. Inayat BP, Harshal M, Shripad B. Quality by design (QbD) approach to formulate in situ gelling system for nose to brain delivery of Fluoxetine hydrochloride: Ex-vivo and In-vivo study. Ars Pharm. 2017; 58(3):107-114.
27. Lakshmi PK and Harini K. Design and Optimization of Thermo-reversible Nasal in situ Gel of Atomoxetine Hydrochloride Using Taguchi Orthogonal Array Design. Dhaka Univ. J. Pharm. Sci. 2019; 18(2):183-193.
28. Mahmoud MO, Nermin EE, Amani MES, Omiya AH. Development and Evaluation of in-situ Nasal Gel Formulations of Nanosized Transferosomal Sumatriptan: Design, Optimization, in vitro and in vivo Evaluation. Drug Design, Development and Therapy, 2019; 13:4413–4430.
Published
How to Cite
Issue
Section
AUTHORS WHO PUBLISH WITH THIS JOURNAL AGREE TO THE FOLLOWING TERMS:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
.